In a 23-year-old woman at 20 weeks gestation with echocardiographic findings of basal septal hypokinesis, preserved ejection fraction (65‑70%), normal left atrial pressure and diastolic function, mild right ventricular hypertrophy, trivial mitral leaflet prolapse that cannot be rolled out, and trace pulmonic regurgitation with a normal pulmonic valve gradient, what is the appropriate next step in management?

Management of Echocardiographic Findings at 20 Weeks Gestation

In this 23-year-old woman at 20 weeks gestation with preserved ejection fraction (65-70%) and only mild structural findings, the appropriate next step is close clinical monitoring with repeat echocardiography in the third trimester (around 28-32 weeks) to reassess cardiac function, while ensuring she receives care through a specialized cardio-obstetric program (COP) given the presence of basal septal hypokinesis and mild RV hypertrophy.

Risk Stratification and Care Setting

The echocardiographic findings warrant careful attention but do not represent immediately life-threatening pathology:

• Preserved systolic function (EF 65-70%) is reassuring
• Basal septal hypokinesis requires monitoring as it may represent early adaptive changes or underlying cardiomyopathy
• Mild RV hypertrophy could reflect normal pregnancy-related hemodynamic changes or early pulmonary vascular changes
• Trivial mitral valve findings and trace pulmonic regurgitation are generally benign

This patient should receive care in a COP setting 1. The Canadian guidelines recommend that moderate-risk pregnancies (which this case represents given the structural abnormalities) receive either exclusive care in a COP or shared care between a COP and local obstetric care after initial evaluation 1.

Specific Monitoring Plan

Serial Echocardiography

• Repeat echocardiography at 28-32 weeks gestation when hemodynamic stress peaks (plasma volume reaches maximum at 24 weeks, and cardiac output increases 30-50% during normal pregnancy) 2
• Assess for:
  • Progression of regional wall motion abnormalities (particularly the basal septal hypokinesis)
  • Development of systolic dysfunction (EF decline)
  • Worsening RV function or development of pulmonary hypertension
  • Changes in diastolic function (E/A ratio, E/e' ratio, deceleration time)
  • Left atrial enlargement (LAVI measurement)

Clinical Surveillance

Monitor for symptoms suggesting cardiac decompensation:

• Dyspnea beyond normal pregnancy-related breathlessness
• Orthopnea or paroxysmal nocturnal dyspnea
• Chest pain or palpitations
• Peripheral edema beyond physiologic pregnancy edema
• Exercise intolerance

Physiologic Context

The hemodynamic changes of pregnancy create significant cardiac stress 2:

• Blood volume increases 40% by 24 weeks
• Cardiac output rises 30-50%
• Heart rate increases from 20 weeks through 32 weeks
• The heart can enlarge up to 30%

These normal adaptations can unmask underlying cardiac pathology or create new dysfunction, particularly in the third trimester when hemodynamic demands peak. The basal septal hypokinesis and mild RV hypertrophy may represent early maladaptive responses to volume loading.

Delivery Planning

Vaginal delivery should be planned unless cardiac decompensation develops 1. Cesarean delivery is reserved for:

• Severely decompensated patients requiring rapid delivery
• Severe pulmonary hypertension (not present in this case)
• Aggressive aortic pathology

A multidisciplinary labor and delivery plan should be documented in the antepartum period for this moderate-risk patient 1. Consider induction at term to ensure appropriate cardiac and obstetric expertise is available.

Critical Pitfalls to Avoid

1. Do not dismiss mild findings as purely physiologic - basal septal hypokinesis with RV hypertrophy warrants surveillance even with preserved EF
2. Do not wait until symptoms develop - subclinical dysfunction can progress rapidly in the third trimester
3. Do not manage in a community setting without COP involvement - these findings require specialized cardio-obstetric expertise
4. Do not assume preserved EF means normal cardiac function - diastolic dysfunction and regional wall motion abnormalities can cause significant morbidity

Medication Considerations

Currently, no cardiac medications are indicated given preserved systolic function and absence of symptoms. However, if heart failure develops:

• Beta-blockers (metoprolol) are safe in pregnancy 1
• Diuretics can be used cautiously if needed
• Avoid ACE inhibitors, ARBs, and ARNIs - these are contraindicated in pregnancy 1

The patient should be counseled that most cardiac medications can be safely continued during breastfeeding if needed postpartum 1.